Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Clinical trial NCT02014259 · COMPLETED
Trial details
- NCT number
- NCT02014259
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-11
- Primary completion
- 2014-10-24
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.